Order reprints

Open Access Open Badges

Worse prognosis of KRAS c.35 G > A mutant metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx)

Gemma Bruera, Katia Cannita, Daniela Di Giacomo, Aude Lamy, Thierry Frébourg, Jean Christophe Sabourin, Mario Tosi, Edoardo Alesse, Corrado Ficorella and Enrico Ricevuto*

BMC Medicine 2013, 11:59  doi:10.1186/1741-7015-11-59

This article is currently available as a provisional PDF. Reprints are produced from the final PDF, which is normally produced within 3 weeks.

Please complete the following form to register your interest in ordering reprints of this article. BioMed Central will contact you by email when the final PDF is available with details of how to obtain a quotation and place an order.

Fields marked * are required